EUVIMEDDescubrir EUVIMED
Open access · CC BY 4.0

Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform

Atakan Tevlek iD, Gunes Kibar, Barbaros Cetin

Biotechnology and Bioengineering · 2025

DOI: 10.1002/bit.29033 ↗

At a glance

Journal article in Biotechnology and Bioengineering, 2025. Written by Atakan Tevlek and 2 co-authors. Institution: Department of Medical Biology, Faculty of Medicine, Atilim University, Ankara, Turkey. Major MEDLINE topics: Aloe, Spheroids, Cellular, Antineoplastic Agents, Liver Neoplasms. Cited 2 times so far (Crossref); 54 references. The full text is freely available (open access, CC BY 4.0). Funded by: The study was supported by the Türkiye Bilimsel ve Teknolojik Arastirma Kurumu..

ResumenSubjectsDatos bibliográficosCiteRelated studies

Abstract (original language)

The search for effective anticancer therapies has increasingly focused on natural compounds like Aloe vera , renowned for its therapeutic properties. This study investigates the anticancer properties of Aloe vera on 3D liver tumor spheroids via a PDMS‐based microfluidic device, providing a more physiologically realistic model compared to traditional 2D cultures. HepG2 cells were cultivated to generate 3D spheroids on‐chip, thereafter subjected to different concentrations of Aloe vera and the chemotherapeutic drug Doxorubicin to evaluate cytotoxic effects. The microfluidic system, validated by COMSOL simulations, facilitated continuous perfusion and real‐time assessment of cell viability over a duration of 10 days. The results indicated that Aloe vera markedly diminished cell viability by triggering apoptosis at concentrations over 12.5 mg/mL. IC50 values were determined at 72 h: 25 ± 0.10 mg/mL for Aloe vera and 5.47 ± 0.03 µg/mL for Doxorubicin in 2D cultures, but in 3D cultures, the IC50 values were 31.25 ± 0.14 mg/mL for Aloe vera and 8.33 ± 0.05 µg/mL for Doxorubicin. This study underscores the promise of Aloe vera as a natural anticancer agent and illustrates the efficacy of microfluidic platforms for enhanced drug screening and customized medicine applications.

Subjects

MeSH terms (MEDLINE)

AloeSpheroids, CellularAntineoplastic AgentsLiver NeoplasmsPlant ExtractsHumansHep G2 CellsCell SurvivalDoxorubicinLab-On-A-Chip DevicesApoptosis

Author keywords

3D cell cultureAloe veraanticancer agentmicrofluidic

Substances

Antineoplastic AgentsDoxorubicinPlant Extracts

Authors and institutions

  • Department of Medical Biology, Faculty of Medicine, Atilim University, Ankara, Turkey.
  • Department of Materials Science and Engineering, Micro Nano Particles (MNP) Research Group, Adana Alparslan Turkes Science and Technology University, Adana, Turkey.
  • UNAM - Institute of Materials Science and Nanotechnology, Bilkent University, Ankara, Turkey.
  • Department of Mechanical Engineering, Microfluidics & Lab-on-a-chip Research Group, Bilkent University, Ankara, Turkey.

ORCID profiles: Atakan Tevlek

Funding

  • The study was supported by the Türkiye Bilimsel ve Teknolojik Arastirma Kurumu.

Cite

APA

Tevlek, A., Kibar, G., & Cetin, B. (2025). Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.29033

Vancouver

Tevlek A, Kibar G, Cetin B. Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform. Biotechnology and Bioengineering. 2025. doi:10.1002/bit.29033

BibTeX
@article{Tevlek2025,
  author = {Tevlek, Atakan and Kibar, Gunes and Cetin, Barbaros},
  title = {Assessment of Anticancer Effects of Aloe vera on 3D Liver Tumor Spheroids in a Microfluidic Platform},
  journal = {Biotechnology and Bioengineering},
  year = {2025},
  doi = {10.1002/bit.29033}
}
Start for free →